Health policy and systems research in access to medicines: a prioritized agenda for low- and middle-income countries
- Location
-
Deutsche Nationalbibliothek Frankfurt am Main
- ISSN
-
1478-4505
- Extent
-
Online-Ressource
- Language
-
Englisch
- Notes
-
online resource.
- Bibliographic citation
-
Health policy and systems research in access to medicines: a prioritized agenda for low- and middle-income countries ; volume:11 ; number:1 ; day:14 ; month:10 ; year:2013 ; pages:1-13 ; date:12.2013
Health research policy and systems ; 11, Heft 1 (14.10.2013), 1-13, 12.2013
- Contributor
-
Bigdeli, Maryam
Javadi, Dena
Hoebert, Joelle
Laing, Richard
Ranson, Kent
SpringerLink (Online service)
- DOI
-
10.1186/1478-4505-11-37
- URN
-
urn:nbn:de:1111-2016070910695
- Rights
-
Der Zugriff auf das Objekt ist unbeschränkt möglich.
- Last update
-
14.08.2025, 10:58 AM CEST
Data provider
This object is provided by:
Deutsche Nationalbibliothek. If you have any questions about the object, please contact the data provider.
Deutsche Nationalbibliothek. If you have any questions about the object, please contact the data provider.
Associated
- Bigdeli, Maryam
- Javadi, Dena
- Hoebert, Joelle
- Laing, Richard
- Ranson, Kent
- SpringerLink (Online service)
Other Objects (12)
Access to cardiovascular medicines in low- and middle-income countries: a mini review
Medicines patents, access and innovation : the growing challenges for people in low and middle-income countries to access new medicines
Future information technology tools for fighting substandard and falsified medicines in low- and middle-income countries
Fighting poor-quality medicines in low- and middle-income countries: the importance of advocacy and pedagogy
Forming a medicines pricing policy for low and middle-income countries (LMICs): the case for Pakistan
Middle-class composition and growth in middle-income countries
Access to innovative cancer medicines in a middle-income country - the case of Mexico
Inequality, aging, and the middle-income trap
Availability, prices, and affordability of selected essential cancer medicines in a middle-income country – the case of Mexico
Evaluating the affordability of asthma, chronic obstructive pulmonary disease, and cystic fibrosis medicines in a middle-income country
Comparison of medicines management strategies in insurance schemes in middle-income countries: four case studies
Mining's contribution to low- and middle-income economies
Access to cardiovascular medicines in low- and middle-income countries: a mini review
Medicines patents, access and innovation : the growing challenges for people in low and middle-income countries to access new medicines
Future information technology tools for fighting substandard and falsified medicines in low- and middle-income countries
Fighting poor-quality medicines in low- and middle-income countries: the importance of advocacy and pedagogy
Forming a medicines pricing policy for low and middle-income countries (LMICs): the case for Pakistan
Middle-class composition and growth in middle-income countries
Access to innovative cancer medicines in a middle-income country - the case of Mexico
Inequality, aging, and the middle-income trap
Availability, prices, and affordability of selected essential cancer medicines in a middle-income country – the case of Mexico
Evaluating the affordability of asthma, chronic obstructive pulmonary disease, and cystic fibrosis medicines in a middle-income country
Comparison of medicines management strategies in insurance schemes in middle-income countries: four case studies
Mining's contribution to low- and middle-income economies
Access to cardiovascular medicines in low- and middle-income countries: a mini review
Medicines patents, access and innovation : the growing challenges for people in low and middle-income countries to access new medicines
Future information technology tools for fighting substandard and falsified medicines in low- and middle-income countries
Fighting poor-quality medicines in low- and middle-income countries: the importance of advocacy and pedagogy
Forming a medicines pricing policy for low and middle-income countries (LMICs): the case for Pakistan
Middle-class composition and growth in middle-income countries
Access to innovative cancer medicines in a middle-income country - the case of Mexico
Inequality, aging, and the middle-income trap
Availability, prices, and affordability of selected essential cancer medicines in a middle-income country – the case of Mexico
Evaluating the affordability of asthma, chronic obstructive pulmonary disease, and cystic fibrosis medicines in a middle-income country
Comparison of medicines management strategies in insurance schemes in middle-income countries: four case studies